Longevity Biotech's Grant

Longevity Biotech raised a round of funding on April 17, 2012. Investors include Breakout Labs.

Longevity Biotech is developing a class of therapeutics via artificial protein technology (Hybridtides). Hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by nat…

Articles about Longevity Biotech's Grant: